Kymera Therapeutics, Inc.

KYMRSEC EDGAR

Biological Products, (No Diagnostic Substances)(DE)CIK: 1815442

Revenue (Latest FY)

$78.6M

Net Income (Latest FY)

-$147.0M

Industry

Biological Products, (No Diagnostic Substances)

Recent Filings

Company Details

CIK1815442

Fiscal Year End1231

CategoryLarge accelerated filer

StateDE

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)